Rayos, a new delayed-release prednisone designed for evening dosing

December 2012

You'll see ads for Rayos, a new delayed-release prednisone designed for evening dosing.

It'll be promoted for rheumatoid arthritis first...then later for COPD, asthma, and other conditions that require an oral steroid.

Rayos tablets are coated to delay drug release for about 4 hours after a dose. Then absorption is similar to immediate-release prednisone.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote